Black patients with ICDs have higher rate of post-implant cardiac events and risk of death

FHS
July 17, 2023
7:12 pm

Black patients with implantable cardioverter defibrillators (ICDs) have a significantly higher burden of disease than white patients with the same device, according to a new study from University of Rochester Medical Center (URMC) cardiology researchers.

Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1 – Biotech Investments

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Miscellaneous Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting

November 4, 2023

Breakthrough research unveils effects of ionizing radiation on cellular DNA

Recent release of the waste water from Japan’s Fukushima nuclear disaster stirred apprehension regarding the health implications of radiation exposure.

February 14, 2024

Sanofi’s Sarclisa gets approved as a first-line option for some patients newly diagnosed with multiple myeloma

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.